BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21757972)

  • 1. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.
    Ryu JK; Matthaei H; Dal Molin M; Hong SM; Canto MI; Schulick RD; Wolfgang C; Goggins MG; Hruban RH; Cope L; Maitra A
    Pancreatology; 2011; 11(3):343-50. PubMed ID: 21757972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyst Fluid Glucose is Rapidly Feasible and Accurate in Diagnosing Mucinous Pancreatic Cysts.
    Zikos T; Pham K; Bowen R; Chen AM; Banerjee S; Friedland S; Dua MM; Norton JA; Poultsides GA; Visser BC; Park WG
    Am J Gastroenterol; 2015 Jun; 110(6):909-14. PubMed ID: 25986360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent Accuracy of Glucose Level in Cystic Fluid for Diagnosis of Pancreatic Mucinous Cysts.
    Faias S; Pereira L; Roque R; Chaves P; Torres J; Cravo M; Pereira AD
    Dig Dis Sci; 2020 Jul; 65(7):2071-2078. PubMed ID: 31705344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts.
    Carr RA; Yip-Schneider MT; Simpson RE; Dolejs S; Schneider JG; Wu H; Ceppa EP; Park W; Schmidt CM
    Surgery; 2018 Mar; 163(3):600-605. PubMed ID: 29241991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts.
    Cizginer S; Turner BG; Bilge AR; Karaca C; Pitman MB; Brugge WR
    Pancreas; 2011 Oct; 40(7):1024-8. PubMed ID: 21775920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyst fluid metabolites distinguish malignant from benign pancreatic cysts.
    Shi J; Yi Z; Jin L; Zhao L; Raskind A; Yeomans L; Nwosu ZC; Simeone DM; Lyssiotis CA; Stringer KA; Kwon RS
    Neoplasia; 2021 Nov; 23(11):1078-1088. PubMed ID: 34583246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
    Matthaei H; Wylie D; Lloyd MB; Dal Molin M; Kemppainen J; Mayo SC; Wolfgang CL; Schulick RD; Langfield L; Andruss BF; Adai AT; Hruban RH; Szafranska-Schwarzbach AE; Maitra A
    Clin Cancer Res; 2012 Sep; 18(17):4713-24. PubMed ID: 22723372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
    Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
    Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
    Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.
    Singhi AD; Nikiforova MN; Fasanella KE; McGrath KM; Pai RK; Ohori NP; Bartholow TL; Brand RE; Chennat JS; Lu X; Papachristou GI; Slivka A; Zeh HJ; Zureikat AH; Lee KK; Tsung A; Mantha GS; Khalid A
    Clin Cancer Res; 2014 Aug; 20(16):4381-9. PubMed ID: 24938521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.
    van der Waaij LA; van Dullemen HM; Porte RJ
    Gastrointest Endosc; 2005 Sep; 62(3):383-9. PubMed ID: 16111956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.
    Farrell JJ; Toste P; Wu N; Li L; Wong J; Malkhassian D; Tran LM; Wu X; Li X; Dawson D; Wu H; Donahue TR
    Am J Gastroenterol; 2013 Aug; 108(8):1352-9. PubMed ID: 23752880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiologic Distribution of Pancreatic Cystic Lesions Identified on Computed Tomography/Magnetic Resonance Imaging.
    Munigala S; Javia SB; Agarwal B
    Pancreas; 2019 Sep; 48(8):1092-1097. PubMed ID: 31404022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of biochemistry and cytological analysis of cyst fluid for the differential diagnosis of pancreatic cysts: A retrospective cohort study.
    Soyer OM; Baran B; Ormeci AC; Sahin D; Gokturk S; Evirgen S; Basar R; Firat P; Akyuz F; Demir K; Besisik F; Kaymakoglu S; Karaca C
    Medicine (Baltimore); 2017 Jan; 96(1):e5513. PubMed ID: 28072692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
    Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
    Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
    Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
    Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.